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DISCUSSION
Given that psoriasis is increasingly recognized to be associated with comorbid conditions of obesity, diabetes, metabolic
dysregulation, and cardiovascular diseases that may be related to inﬂammation in skin (Davidovici et al., 2010), it is of interest
that associated functional pathways were also identiﬁed through IPA, including metabolic disease and cardiovascular disease
(Supplementary Figure S1b online), leading to two potential mechanisms for increased association between psoriasis and
metabolic and cardiovascular comorbidities.First, a product made in psoriatic plaques could produce diffusible hormone-like
proteins that inﬂuence the biology of distant cells/tissues (e.g., renin, vascular endothelial growth factor, and monocyte
chemoattractant 9 protein-1 (CCL2); Table 4) and IL-17 A (Supplementary Figure S2 online).
MATERIALS AND METHODS
Serum protein proﬁling
A 92-protein vendor-deﬁned multiplex Luminex-based panel (Human Map 1.6 plus IL-17 and IL-23; Rules Based Medicine, Austin, TX) was
used to proﬁle differential serum protein expression from healthy volunteers (n= 162) and patients with psoriasis (n= 149). The complete list of
analytes in the Human Map 1.6 can be found at http://rulesbasedmedicine.com/products-services/humanmap-services/human-discoverymap.
A more sensitive immunoassay, an IL-17A single-plex assay (Singulex, CA) was used to quantify IL-17A in serum from healthy
and psoriatic subjects (n= 10 in each group).
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